title: The effects of valproate and phenytoin on the cAMP and cGMP levels in nervous tissue.
abstract: Earlier studies have demonstrated that valproic acid (VPA) and phenytoin (PHT) influence the excitability properties of crayfish axons through different mechanisms. PHT was found to antagonize the electrophysiologic effects of VPA. The purpose of the present study was to determine if the electrophysiologic effects of VPA and PHT are correlated with changes in the cellular levels of either cAMP or cGMP as these substances are known to influence membrane excitability. It was found that PHT (0.1 mM) has no effect on the levels of either cAMP or cGMP within crayfish neural tissue. VPA (4.0 mM) also has no effect on cAMP levels. However, it does significantly reduce the levels of cGMP. Pretreatment of neural tissue with PHT has been shown to eliminate the effects of VPA on membrane excitability. It was found that this pretreatment has no influence on VPA's ability to reduce cGMP levels. The effect of VPA on cGMP levels is observed in the absence of spontaneous activity. Therefore, it is concluded that the observed reduction in cGMP levels does not represent the modulation of cGMP levels that is known to accompany activity. Two experiments demonstrate that the 4-mV depolarization of membranes by VPA can not account for its effect on cGMP levels. In the first, pretreatment with PHT abolished the depolarizing effect on VPA but not its effect on cGMP. In the second, a concentration of ouabain which depolarizes crayfish neural tissue by 8-10 mV without producing spike activity had no effect on either cAMP or cGMP levels. These experiments effectively dissociate the electrophysiologic response to VPA and PHT from changes in cyclic nucleotide levels.
authors.forename: T M
authors.initials: TM
authors.lastname: Nosek
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D003400:Astacoidea; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D000242:Cyclic AMP / Q000032:analysis*; D006152:Cyclic GMP / Q000032:analysis*; D008564:Membrane Potentials / Q000187:drug effects; D009417:Nerve Tissue / Q000032:analysis / Q000187:drug effects*; D010672:Phenytoin / Q000494:pharmacology*; D013116:Spinal Cord / Q000032:analysis / Q000187:drug effects; D014635:Valproic Acid / Q000494:pharmacology*
chemical_list: D014635:Valproic Acid; D010672:Phenytoin; D000242:Cyclic AMP; D006152:Cyclic GMP